Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
The company received U.S. Food and Drug Administration clearance last week.
June 15, 2026
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
The company received U.S. Food and Drug Administration clearance last week.